AMGEN APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS

Rhea-AI Summary

Amgen has appointed Michael V. Drake, M.D., to its Board of Directors, effective immediately, bringing the board's total to 13 members, 12 of whom are independent. Dr. Drake, currently the president of the University of California system, has prior leadership experience at The Ohio State University and UC Irvine. His extensive background in medicine and academia is expected to enhance Amgen's innovation efforts in treating serious illnesses.

Positive

• Michael V. Drake's extensive medical and leadership experience is likely to add significant value to Amgen's innovation strategy.
• Drake's successful tenure in leadership roles at major academic institutions suggests a strong ability to enhance governance and oversight.

Negative

• None.

THOUSAND OAKS, Calif., Aug. 3, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of Michael V. Drake, M.D., to its Board of Directors, effective immediately.  Dr. Drake will also serve as a member of the Board's Corporate Responsibility and Compliance Committee and its Governance and Nominating Committee.  Following the appointment of Dr. Drake, the Board will be composed of 13 directors, 12 of whom are independent.

Dr. Drake is president of the University of California, a system of 10 campuses, five medical centers and three nationally affiliated labs that serves more than 280,000 students and employs 230,000 faculty and staff.

"Michael is an accomplished physician and leader who heads one of the largest, most diverse and well-respected academic institutions in the world," said Robert A. Bradway, chairman and chief executive officer of Amgen.  "He will add tremendous value to Amgen given his extensive medical, scientific and leadership experience as we continue to drive innovation to address serious illness."

Dr. Drake previously served as president of The Ohio State University (OSU) from 2014 to 2020, a period during which the university saw all-time highs in applications, graduation rates, industry-sponsored research and academic preparation and diversity of in-coming classes.  Prior to OSU, he served for nine years as chancellor of the University of California, Irvine and was UC Irvine's systemwide vice president for health affairs from 2000 to 2005.

Dr. Drake received his undergraduate degree from Stanford University and his medical doctorate from the University of California, San Francisco. 

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.  In 2021, Amgen was named one of the 25 World's Best Workplaces™ by Fortune and Great Place to Work™ and one of the 100 most sustainable companies in the world by Barron's.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Jessica Akopyan, 805-440-5721 (media) 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-appoints-michael-v-drake-to-board-of-directors-301599348.html

SOURCE Amgen

FAQ

Who is Michael V. Drake and what role will he play at Amgen?

Michael V. Drake is an accomplished physician and president of the University of California system. He will serve on Amgen's Board of Directors and its Corporate Responsibility and Compliance Committee, contributing to its governance.

What experience does Michael V. Drake bring to Amgen?

Dr. Drake has extensive leadership experience, previously serving as president of The Ohio State University and chancellor of UC Irvine, enhancing his ability to drive innovation in healthcare.

What is the current composition of Amgen's Board of Directors?

Following the appointment of Dr. Drake, Amgen's Board consists of 13 directors, with 12 being independent members.

How might Michael V. Drake's appointment impact Amgen's future?

Dr. Drake's appointment is expected to strengthen Amgen's focus on innovation and governance, leveraging his background in medicine and academia to address serious health issues.